[HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
D000225:Adenine / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000191:economics*; D000284:Administration, Oral; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000191:economics; D003906:Developing Countries; D016527:Drug Costs / Q000706:statistics & numerical data*; D004345:Drug Industry / Q000191:economics; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics*; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage* / Q000191:economics*; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D000068698:Tenofovir; D000225:Adenine